Common 1-3 Contraindications 1-3 Hypersensitivity to GHK, copper peptides or excipients Active local infection, open wounds, or compromised skin barrier at site of application Precautions 1-3 Avoid contact with mucous membranes and eyes This information is for educational purposes only
The resulting reduction in systemic inflammatory burden is believed to be a central mechanism through which GLP-1 therapy confers cancer-protective effects
These changes are largely the result of : - Rapid weight loss - Significant loss of muscle and connective tissue - Reduced structural support under the skin The Result : - Sagging facial skin - Sunken cheeks - Flattened or loose gluteal tissue - Accelerated appearance of aging This is not simply fat loss it is loss of tissue integrity, which becomes more noticeable when muscle mass is stripped away
HIMS to Introduce Compounded GLP-1 Injections, What Plan Sponsors Need to Know Scripta May 28, 2024 3 min read Updated: Jun 14, 2024 Hims & Hers' (HIMS) latest move to introduce compounded GLP-1 injections into its weight loss program is stirring up excitement and raising a few eyebrows among plan sponsors
Also, Metsera described that MET-097i has a bias for cAMP activity and less for B-arrestin pathway which could be potentially stemming from this C-terminus lipidation approach